News

While immunotherapy has been successful for a number of aggressive cancers, acute myeloid leukemia (AML), a hematologic malignancy with dismal outcomes, has no currently known immunotherapy targets. In a recently published study in Nature Cancer, Arun Wiita, MD, PhD reports the hurdles and successes

UCSF Health hospitals at Mission Bay, Parnassus Heights and Mount Zion have earned an “A” Hospital Safety Grade from the health care transparency nonprofit, The Leapfrog Group. Fewer than 1 in 3 hospitals nationwide can say the same. The Leapfrog Hospital Safety Grade assigns letter grades to

When Associate Professor of Otolaryngology Matthew Spitzer, PhD, was in fifth grade, his mom was diagnosed with breast cancer. She passed away while he was in college. “That was a strong motivating force for me to get involved in cancer research,” Dr. Spitzer said. Shortly thereafter, Dr. Spitzer

With a renewed Specialized Program of Research Excellence (SPORE) grant, the UC San Francisco Brain Tumor Center is receiving $12 million dollars over five years to translate scientific findings into improved care for people with brain tumors. The award marks the fifth cycle of continuous support

It took three years and thousands of dollars in fundraising, but the legacy of a celebrated UCSF professor and researcher has now been cemented in a lecture hall for generations of learners to come. The inaugural Zena Werb Memorial Lecture in Cancer Biology took place at UCSF Parnassus Heights

A recent article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer. Authors include UCSF Radiology and Biomedical Imaging faculty members Thomas Hope, MD, Roxanna Juarez, MD, Miguel